human milk Search Results


96
ATCC l reuteri atcc pta 6475 rect1
L Reuteri Atcc Pta 6475 Rect1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/pmc03476877-62-1-3?v=ATCC
Average 96 stars, based on 1 article reviews
l reuteri atcc pta 6475 rect1 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

93
Innovative Research Inc human breast milk
Human Breast Milk, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/pmc06410085-71-0-7?v=Innovative+Research+Inc
Average 93 stars, based on 1 article reviews
human breast milk - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

92
Lee Biosolutions human breast milk
Human Breast Milk, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/us11986445-578-34-51?v=Lee+Biosolutions
Average 92 stars, based on 1 article reviews
human breast milk - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

94
Elabscience Biotechnology mfge8
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
Mfge8, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/pmc12864137-109-3-15?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
mfge8 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

88
Lee Biosolutions breastmilk
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
Breastmilk, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/pm31759609-49-1-10?v=Lee+Biosolutions
Average 88 stars, based on 1 article reviews
breastmilk - by Bioz Stars, 2026-08
88/100 stars
  Buy from Supplier

94
Gold Biotechnology Inc human egf
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
Human Egf, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/pmc04705856-48-6-11?v=Gold+Biotechnology+Inc
Average 94 stars, based on 1 article reviews
human egf - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
Gold Biotechnology Inc number: 1150-04-100
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
Number: 1150 04 100, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/bio_rxiv__2025__08__14__670284-198-12-9?v=Gold+Biotechnology+Inc
Average 94 stars, based on 1 article reviews
number: 1150-04-100 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
Gold Biotechnology Inc egf
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
Egf, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/pm37363726-62-38-39?v=Gold+Biotechnology+Inc
Average 94 stars, based on 1 article reviews
egf - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

91
Boster Bio s100 β
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
S100 β, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/pm35986421-98-12-18?v=Boster+Bio
Average 91 stars, based on 1 article reviews
s100 β - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

90
Cusabio elisa kits
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
Elisa Kits, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/pmc04671530-34-11-14?v=Cusabio
Average 90 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Biosynth Carbosynth human milk oligosaccharides
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
Human Milk Oligosaccharides, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/us11319567-239-10-16?v=Biosynth+Carbosynth
Average 93 stars, based on 1 article reviews
human milk oligosaccharides - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

85
Lee Biosolutions human apo 343 lactoferrin
Serum biomarker concentrations over time after TBI. Serum levels of (A) <t>MFGE8,</t> (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.
Human Apo 343 Lactoferrin, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+milk/10__1128_slash_iai__02486___14-164-25-28?v=Lee+Biosolutions
Average 85 stars, based on 1 article reviews
human apo 343 lactoferrin - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier

Image Search Results


Serum biomarker concentrations over time after TBI. Serum levels of (A) MFGE8, (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.

Journal: Frontiers in Neurology

Article Title: Serial assessment of the novel biomarker MFGE8 in comparison with GFAP for predicting severity and outcome after traumatic brain injury

doi: 10.3389/fneur.2026.1750940

Figure Lengend Snippet: Serum biomarker concentrations over time after TBI. Serum levels of (A) MFGE8, (B) GFAP, and (C) the GFAP/MFGE8 ratio were measured in healthy controls and at admission, 24 h, 48 h, and 72 h after TBI. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.

Article Snippet: Serum levels of MFGE8 (E-EL-H2063) and GFAP (E-EL-H6093) were measured using a double-antibody sandwich ELISA (Elabscience Biotechnology Co., Ltd).

Techniques: Biomarker Discovery, Transformation Assay

Temporal distribution of serum MFGE8 and GFAP levels, and the GFAP/MFGE8 ratio across TBI severity groups based on GCS scores. Serum levels of MFGE8, GFAP, and the GFAP/MFGE8 ratio in patients with (A) mild, (B) moderate, and (C) severe TBI (stratified by GCS) at admission and at 24, 48, and 72 h post-injury. Each row represents a distinct TBI severity group. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.

Journal: Frontiers in Neurology

Article Title: Serial assessment of the novel biomarker MFGE8 in comparison with GFAP for predicting severity and outcome after traumatic brain injury

doi: 10.3389/fneur.2026.1750940

Figure Lengend Snippet: Temporal distribution of serum MFGE8 and GFAP levels, and the GFAP/MFGE8 ratio across TBI severity groups based on GCS scores. Serum levels of MFGE8, GFAP, and the GFAP/MFGE8 ratio in patients with (A) mild, (B) moderate, and (C) severe TBI (stratified by GCS) at admission and at 24, 48, and 72 h post-injury. Each row represents a distinct TBI severity group. Data are presented as scatter-box plots (median with interquartile range) with log 10 -transformed concentrations.

Article Snippet: Serum levels of MFGE8 (E-EL-H2063) and GFAP (E-EL-H6093) were measured using a double-antibody sandwich ELISA (Elabscience Biotechnology Co., Ltd).

Techniques: Transformation Assay

Temporal profiles of serum MFGE8 and GFAP levels stratified by clinical outcomes. Line charts depict the temporal trajectories of serum (A) MFGE8 and (B) GFAP concentrations stratified by clinical outcomes, categorized as favorable alive (GOSE 5–8), unfavorable alive (GOSE 2–4), and death (GOSE 1), measured at admission and at 24, 48, and 72 h after traumatic brain injury. Data points represent median values, and shaded areas indicate the interquartile range (IQR).

Journal: Frontiers in Neurology

Article Title: Serial assessment of the novel biomarker MFGE8 in comparison with GFAP for predicting severity and outcome after traumatic brain injury

doi: 10.3389/fneur.2026.1750940

Figure Lengend Snippet: Temporal profiles of serum MFGE8 and GFAP levels stratified by clinical outcomes. Line charts depict the temporal trajectories of serum (A) MFGE8 and (B) GFAP concentrations stratified by clinical outcomes, categorized as favorable alive (GOSE 5–8), unfavorable alive (GOSE 2–4), and death (GOSE 1), measured at admission and at 24, 48, and 72 h after traumatic brain injury. Data points represent median values, and shaded areas indicate the interquartile range (IQR).

Article Snippet: Serum levels of MFGE8 (E-EL-H2063) and GFAP (E-EL-H6093) were measured using a double-antibody sandwich ELISA (Elabscience Biotechnology Co., Ltd).

Techniques:

ROC curve analysis of MFGE8, GFAP, and the GFAP/MFGE8 ratio for predicting 30-day mortality risk.

Journal: Frontiers in Neurology

Article Title: Serial assessment of the novel biomarker MFGE8 in comparison with GFAP for predicting severity and outcome after traumatic brain injury

doi: 10.3389/fneur.2026.1750940

Figure Lengend Snippet: ROC curve analysis of MFGE8, GFAP, and the GFAP/MFGE8 ratio for predicting 30-day mortality risk.

Article Snippet: Serum levels of MFGE8 (E-EL-H2063) and GFAP (E-EL-H6093) were measured using a double-antibody sandwich ELISA (Elabscience Biotechnology Co., Ltd).

Techniques: